Prognostic significance of clusterin immunoreactivity in breast cancer.

Neoplasma

Volumn 54, Issue 1, 2007, Pages 46-50

  Kruger S ^a   Ola, V ^a   Fischer, D ^a   Feller, A C ^a   Friedrich, M ^a  

^a Institute of Pathology and Department of Gynecology and Obstetrics   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLU PROTEIN, HUMAN; CLUSTERIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST TUMOR; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CLUSTERIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS;

EID: 34250807657     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)